XML 79 R59.htm IDEA: XBRL DOCUMENT v3.26.1
Stock-Based Compensation Expense - Schedule of Stock Options Vested and Exercisable (Details) - USD ($)
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2025
Schedule of Stock Options Vested and Exercisable [Abstract]    
Shares, outstanding at Ending balance 1,151 924
Weighted-average exercise price, outstanding at Ending balance (in Dollars per share) $ 14,665.36 $ 13,475.78
Weighted-average remaining contractual term (years), outstanding at Ending balance 7 years 4 months 13 days 4 years 4 months 28 days
Aggregate intrinsic value, outstanding at Ending balance (in Dollars)
Shares, vested and expected to vest at ending balance   924
Weighted-average exercise price, vested and expected to vest at ending balance (in Dollars per share)   $ 13,475.78
Weighted-average remaining contractual term (years), vested and expected to vest at ending balance   4 years 4 months 28 days
Aggregate intrinsic value, vested and expected to vest at ending balance (in Dollars)  
Shares, vested and exercisable at ending balance   764
Weighted-average exercise price, vested and exercisable at ending balance (in Dollars per share)   $ 13,264.58
Weighted-average exercise price, vested and exercisable at ending balance   3 years 11 months 12 days
Aggregate intrinsic value, vested and exercisable at ending balance (in Dollars)  
Shares, Granted  
Weighted- average exercise price, Granted (in Dollars per share)  
Aggregate intrinsic value, Granted  
Shares, Exercised  
Weighted-average exercise price, Exercised (in Dollars per share)  
Aggregate intrinsic value, Exercised (in Dollars)  
Shares, Cancelled/forfeited   (227)
Weighted-average exercise price, Cancelled/forfeited (in Dollars per share)   $ 19,438.45